-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 10, the State Food and Drug Administration issued a notice that 16 batches of drugs did not meet the requirements
Unqualified varieties:
Solid preparations: compound clotrimazole cream (2 batches), Gucining capsules, joint pain ointment (3 batches), Huanglian Shangqing pills, Keteling capsules, Jiawei Huoxiang Zhengqi pills
Chinese herbal medicine pieces: Qingfengzi (3 batches), Bupleurum (3 batches), Bupleurum (North Bupleurum)
Unqualified test items:
Solid preparations: microbial limit (2 batches), loading water, content determination, loading difference, identification
Chinese herbal medicine pieces: traits (6 batches), impurities
The following is the original text:
After inspection by 8 drug inspection institutions including Anhui Food and Drug Inspection and Research Institute, 16 batches of drugs including compound clotrimazole cream produced by 14 companies including Hebei Jiuzheng Pharmaceutical Co.
1.
After inspection by Shanxi Provincial Food and Drug Inspection Institute, it is indicated that the entrusting party is Shanxi Tianzhi Pharmaceutical Co.
The three batches of joint pain relief ointment produced by Jiangsu Baiyi Pharmaceutical Co.
A batch of Huanglian Shangqing Pills produced by Sichuan Qiyun Pharmaceutical Co.
After inspection by the Tibet Autonomous Region Food and Drug Inspection and Research Institute, a batch of Keteling capsules produced by Yili Pharmaceutical Co.
After inspection by Wuhan Institute of Drug and Medical Device Inspection, a batch of Jiawei Huoxiang Zhengqi Pills produced by Guangzhou Yuehua Pharmaceutical Co.
After inspection by China National Institute for Food and Drug Control, the three batches of argentea produced by Anhui Jiancheng Chinese Medicine Decoction Pieces Co.
According to the inspection by Gansu Provincial Institute of Drug Inspection, the 2 batches of Bupleurum spp.
2.
3.
Hereby inform
Appendix:
1.
2.
State Food and Drug Administration
June 8, 2021